(a) A voting board member may not have a contractual relationship with, ownership interest in, or other conflict of interest with:
- (1) a pharmaceutical manufacturer or labeler; or
- (2) an entity the commission engages to assist in developing preferred drug lists or administering the Medicaid Drug Utilization Review Program.
(b) The executive commissioner may implement this section by:
- (1) adopting rules that identify prohibited relationships and conflicts; or
- (2) requiring the board to develop a conflict-of-interest policy that applies to the board.
Added by Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611), Sec. 1.01, eff. April 1, 2025.